{"version":"1.0","provider_name":"Clario","provider_url":"https:\/\/clario.com","author_name":"Gary Norman","author_url":"https:\/\/clario.com\/author\/garyn\/","title":"Clario and the University of Oxford\u2019s NeuroMetrology Lab Advance Parkinson\u2019s Disease Research with the Opal\u00ae Wearable Sensor System | Clario","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"l4hn2ZWrkq\"><a href=\"https:\/\/clario.com\/about\/newsroom\/clario-and-the-university-of-oxfords-neurometrology-lab-advance-parkinsons-disease-research-with-the-opal-wearable-sensor-system\/\">Clario and the University of Oxford\u2019s NeuroMetrology Lab Advance Parkinson\u2019s Disease Research with the Opal\u00ae Wearable Sensor System<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/clario.com\/about\/newsroom\/clario-and-the-university-of-oxfords-neurometrology-lab-advance-parkinsons-disease-research-with-the-opal-wearable-sensor-system\/embed\/#?secret=l4hn2ZWrkq\" width=\"600\" height=\"338\" title=\"&#8220;Clario and the University of Oxford\u2019s NeuroMetrology Lab Advance Parkinson\u2019s Disease Research with the Opal\u00ae Wearable Sensor System&#8221; &#8212; Clario\" data-secret=\"l4hn2ZWrkq\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","description":"PHILADELPHIA \u2013 October 6, 2025 \u2013&nbsp;Clario, a leading provider of endpoint data solutions for clinical trials, today announced the enrollment of the first participant in its collaboration with the University of Oxford\u2019s NeuroMetrology Lab, led by Professor Chrystalina Antoniades. The partnership is focused on advancing the use of Clario\u2019s Opal\u00ae wearable sensor system to enhance","thumbnail_url":"https:\/\/clario.com\/wp-content\/uploads\/2021\/11\/Clario-Website-Open-Graph-Image.jpg","thumbnail_width":1200,"thumbnail_height":627}